A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novartis initiates Phase 3 clinical trial for pelacarsen in US Black/African American & hispanic populations with established atherosclerotic cardiovascular disease; trial yet to open for recruiting

AstraZeneca initiates a Phase 3 clinical trial to evaluate the effectiveness of baxdrostat in combination with dapagliflozin for treating chronic kidney disease in patients with high blood pressure; the trial will involve 2500 participants from the US

ViiV Healthcare's long-acting injectable antiretroviral treatment for HIV, Cabenuva, shows superior efficacy in maintaining viral load suppression compared to daily oral therapy; results come from interim results from Phase 3 trial

Morgan Stanley: Eli Lilly may become first biopharma firm to hit US$1T valuation with help of orally administered GLP-1 drug Orforglipron, whose phase 3 trial results are due in 2025; Lilly now offers injectable Tirzepatide under Mounjaro, Zepbound labels

Eli Lilly lists Phase 3 trial to compare retatrutide with semaglutide in type 2 diabetes patients with inadequate glycemic control; study will include 1,250 participants and run for about 26 months

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count